Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | COVID-19 Vaccination | Research

Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela

Authors: Fabián R. Chacón-Labrador, María G. Passantino, Augusto Moncada-Ortega, Atahualpa A. Ávila, Andrea A. Moreno, Nicolle A. Kuffaty-Akkou, Luisana M. Pedroza, Natasha A. Camejo-Ávila, Daniela L. Mendoza-Millán, Carlis M. Rodriguez-Saavedra, María V. Marcano-Rojas, Fernando Hernández-Medina, María E. Grillet, Fhabián S. Carrión-Nessi, David A. Forero-Peña

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Despite nearly a quarter of Venezuelans remaining unvaccinated against coronavirus disease 2019 (COVID-19), the factors contributing to vaccine hesitancy in the country have not been thoroughly investigated.

Methods

A cross-sectional study was conducted from October 15th to 30th, 2022, using a knowledge, attitudes, and practices (KAP) survey to identify factors associated with COVID-19 vaccine hesitancy.

Results

The study analyzed data from 1,930 participants from all 24 states of Venezuela. The majority (93.4%) were vaccinated. The mean age was 40 years, predominantly female (67.3%), and held a university degree (70.6%). The mean KAP score was significantly higher among vaccinated individuals compared to unvaccinated ones (7.79 vs. 3.94 points for knowledge, 40 vs. 24 points for attitudes, and 16 vs. 10 points for practices, all p < 0.001). Increases in the scores for KAP were associated with increased odds of being vaccinated (84.6%, 25.6%, and 33% respectively for each one-point increase, all p < 0.001). Certain demographic factors such as marital status, occupation, religious beliefs, monthly income, and location influence COVID-19 vaccine knowledge. Higher income and certain occupations decrease the odds of low knowledge, while residing in specific states increases it. Attitudes towards the COVID-19 vaccine are influenced by age, health status, vaccination status, and location. Higher income and absence of certain health conditions decrease the odds of negative attitudes. Lastly, age, occupation, monthly income, and location affect vaccine practices. Advanced age and higher income decrease the odds of inappropriate practices, while residing in La Guaira state increases them.

Conclusion

Factors such as age, education level, occupation, monthly income, and location were found to be associated with knowledge and attitudes towards COVID-19 vaccine among the surveyed Venezuelans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andrade G. Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: a cross-sectional study. Vacunas. 2022;23:S22–5.CrossRefPubMed Andrade G. Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: a cross-sectional study. Vacunas. 2022;23:S22–5.CrossRefPubMed
2.
go back to reference Page KR, Doocy S, Reyna Ganteaume F, Castro JS, Spiegel P, Beyrer C. Venezuela’s public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–60.CrossRefPubMed Page KR, Doocy S, Reyna Ganteaume F, Castro JS, Spiegel P, Beyrer C. Venezuela’s public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–60.CrossRefPubMed
3.
go back to reference Paniz-Mondolfi AE, Tami A, Grillet ME, Márquez M, Hernández-Villena J, Escalona-Rodríguez MA, Blohm GM, Mejías I, Urbina-Medina H, Rísquez A, et al. Resurgence of vaccine-preventable diseases in Venezuela as a Regional Public Health Threat in the Americas. Emerg Infect Dis. 2019;25(4):625–32.CrossRefPubMedPubMedCentral Paniz-Mondolfi AE, Tami A, Grillet ME, Márquez M, Hernández-Villena J, Escalona-Rodríguez MA, Blohm GM, Mejías I, Urbina-Medina H, Rísquez A, et al. Resurgence of vaccine-preventable diseases in Venezuela as a Regional Public Health Threat in the Americas. Emerg Infect Dis. 2019;25(4):625–32.CrossRefPubMedPubMedCentral
5.
go back to reference Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, Grijalva MJ. COVID-19 vaccine hesitancy in three latin American countries: reasons given for not becoming vaccinated in Colombia, Ecuador, and Venezuela. Health Commun. 2022;37(12):1465–75.CrossRefPubMed Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, Grijalva MJ. COVID-19 vaccine hesitancy in three latin American countries: reasons given for not becoming vaccinated in Colombia, Ecuador, and Venezuela. Health Commun. 2022;37(12):1465–75.CrossRefPubMed
6.
go back to reference UCAB. In: Caracas DF, editor. Encuesta Nacional De Condiciones De Vida 2022. Universidad Católica Andrés Bello; 2022. UCAB. In: Caracas DF, editor. Encuesta Nacional De Condiciones De Vida 2022. Universidad Católica Andrés Bello; 2022.
8.
go back to reference Juin JCY, Ern SLS, Min C, Jing NK, Qi MNM, Hoe RCC, Ling TCX, Yi FFJ, Germain GSL, Venkatesh KNS, et al. Knowledge, attitudes, and practices of COVID-19 vaccination among adults in Singapore: a cross-sectional study. Am J Trop Med Hyg. 2022;107(3):540–50.CrossRefPubMed Juin JCY, Ern SLS, Min C, Jing NK, Qi MNM, Hoe RCC, Ling TCX, Yi FFJ, Germain GSL, Venkatesh KNS, et al. Knowledge, attitudes, and practices of COVID-19 vaccination among adults in Singapore: a cross-sectional study. Am J Trop Med Hyg. 2022;107(3):540–50.CrossRefPubMed
9.
go back to reference Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.CrossRefPubMed Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.CrossRefPubMed
10.
go back to reference Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Ng N, Leach S, Gisslén M, Hammar N, Nyberg F, et al. An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden. Vaccine. 2022;40(46):6640–8.CrossRefPubMedPubMedCentral Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Ng N, Leach S, Gisslén M, Hammar N, Nyberg F, et al. An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden. Vaccine. 2022;40(46):6640–8.CrossRefPubMedPubMedCentral
11.
go back to reference Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: a web-based National Survey. J Multidisciplinary Healthc. 2020;13:1657–63.CrossRef Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: a web-based National Survey. J Multidisciplinary Healthc. 2020;13:1657–63.CrossRef
12.
go back to reference Brackstone K, Marzo RR, Bahari R, Head MG, Patalinghug ME, Su TT. COVID-19 vaccine hesitancy and confidence in the Philippines and Malaysia: a cross-sectional study of sociodemographic factors and digital health literacy. PLOS Global Public Health. 2022;2(10):e0000742.CrossRefPubMedPubMedCentral Brackstone K, Marzo RR, Bahari R, Head MG, Patalinghug ME, Su TT. COVID-19 vaccine hesitancy and confidence in the Philippines and Malaysia: a cross-sectional study of sociodemographic factors and digital health literacy. PLOS Global Public Health. 2022;2(10):e0000742.CrossRefPubMedPubMedCentral
13.
go back to reference Marzo RR, Shrestha R, Sapkota B, Acharya S, Shrestha N, Pokharel M, Ahmad A, Patalinghug ME, Rahman F, Salim ZR, et al. Perception towards vaccine effectiveness in controlling COVID-19 spread in rural and urban communities: a global survey. Front Public Health. 2022;10:958668.CrossRefPubMedPubMedCentral Marzo RR, Shrestha R, Sapkota B, Acharya S, Shrestha N, Pokharel M, Ahmad A, Patalinghug ME, Rahman F, Salim ZR, et al. Perception towards vaccine effectiveness in controlling COVID-19 spread in rural and urban communities: a global survey. Front Public Health. 2022;10:958668.CrossRefPubMedPubMedCentral
16.
go back to reference Noh Y, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Lee SW, Shin JY. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey. Epidemiol Health. 2022;44:e2022061.CrossRefPubMedPubMedCentral Noh Y, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Lee SW, Shin JY. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey. Epidemiol Health. 2022;44:e2022061.CrossRefPubMedPubMedCentral
17.
go back to reference Urrunaga-Pastor D, Fernandez-Guzman D, Caira-Chuquineyra B, Herrera-Añazco P, Benites-Zapata VA, Bendezu-Quispe G. Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean. Travel Med Infect Dis. 2022;50:102409.CrossRefPubMedPubMedCentral Urrunaga-Pastor D, Fernandez-Guzman D, Caira-Chuquineyra B, Herrera-Añazco P, Benites-Zapata VA, Bendezu-Quispe G. Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean. Travel Med Infect Dis. 2022;50:102409.CrossRefPubMedPubMedCentral
18.
go back to reference Haktanir A, Can N, Seki T, Kurnaz MF, Dilmaç B. Do we experience pandemic fatigue? Current state, predictors, and prevention. Curr Psychol (New Brunsw NJ). 2022;41(10):7314–25.CrossRef Haktanir A, Can N, Seki T, Kurnaz MF, Dilmaç B. Do we experience pandemic fatigue? Current state, predictors, and prevention. Curr Psychol (New Brunsw NJ). 2022;41(10):7314–25.CrossRef
19.
go back to reference Papagiannis D, Malli F, Raptis DG, Papathanasiou IV, Fradelos EC, Daniil Z, Rachiotis G, Gourgoulianis KI. Assessment of Knowledge, attitudes, and practices towards New Coronavirus (SARS-CoV-2) of Health Care professionals in Greece before the outbreak period. Int J Environ Res Public Health 2020, 17(14). Papagiannis D, Malli F, Raptis DG, Papathanasiou IV, Fradelos EC, Daniil Z, Rachiotis G, Gourgoulianis KI. Assessment of Knowledge, attitudes, and practices towards New Coronavirus (SARS-CoV-2) of Health Care professionals in Greece before the outbreak period. Int J Environ Res Public Health 2020, 17(14).
20.
go back to reference Muluneh MD, Negash K, Tsegaye S, Abera Y, Tadesse D, Abebe S, Vaughan C, Stulz V. COVID-19 knowledge, attitudes, and Vaccine Hesitancy in Ethiopia: A Community-based cross-sectional study. Vaccines (Basel) 2023, 11(4). Muluneh MD, Negash K, Tsegaye S, Abera Y, Tadesse D, Abebe S, Vaughan C, Stulz V. COVID-19 knowledge, attitudes, and Vaccine Hesitancy in Ethiopia: A Community-based cross-sectional study. Vaccines (Basel) 2023, 11(4).
21.
go back to reference Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. Knowledge, acceptance and perception on COVID-19 vaccine among malaysians: a web-based survey. PLoS ONE. 2021;16(8):e0256110.CrossRefPubMedPubMedCentral Mohamed NA, Solehan HM, Mohd Rani MD, Ithnin M, Che Isahak CI. Knowledge, acceptance and perception on COVID-19 vaccine among malaysians: a web-based survey. PLoS ONE. 2021;16(8):e0256110.CrossRefPubMedPubMedCentral
22.
go back to reference ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12:692.CrossRefPubMedPubMedCentral ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12:692.CrossRefPubMedPubMedCentral
23.
go back to reference Chávez PA, Julca AB, Valverde-Rondo M, Ramírez GJ, Miranda MÑ. Conocimientos Y actitudes Frente A La Vacuna Contra El Covid-19%J Revista De La Facultad De Medicina Humana. 2022, 22:244–51. Chávez PA, Julca AB, Valverde-Rondo M, Ramírez GJ, Miranda MÑ. Conocimientos Y actitudes Frente A La Vacuna Contra El Covid-19%J Revista De La Facultad De Medicina Humana. 2022, 22:244–51.
24.
go back to reference Marzo RR, Ahmad A, Islam MS, Essar MY, Heidler P, King I, Thiyagarajan A, Jermsittiparsert K, Songwathana K, Younus DA, et al. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: a global survey of 20 countries. PLoS Negl Trop Dis. 2022;16(1):e0010103.CrossRefPubMedPubMedCentral Marzo RR, Ahmad A, Islam MS, Essar MY, Heidler P, King I, Thiyagarajan A, Jermsittiparsert K, Songwathana K, Younus DA, et al. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: a global survey of 20 countries. PLoS Negl Trop Dis. 2022;16(1):e0010103.CrossRefPubMedPubMedCentral
25.
go back to reference King I, Heidler P, Marzo RR. The Long and Winding Road: Uptake, Acceptability, and potential influencing factors of COVID-19 vaccination in Austria. Vaccines (Basel) 2021, 9(7). King I, Heidler P, Marzo RR. The Long and Winding Road: Uptake, Acceptability, and potential influencing factors of COVID-19 vaccination in Austria. Vaccines (Basel) 2021, 9(7).
26.
go back to reference Marzo RR, Su TT, Ismail R, Htay MNN, Essar MY, Chauhan S, Patalinghug ME, Kucuk Bicer B, Respati T, Fitriyana S, et al. Digital health literacy for COVID-19 vaccination and intention to be immunized: a cross sectional multi-country study among the general adult population. Front Public Health. 2022;10:998234.CrossRefPubMedPubMedCentral Marzo RR, Su TT, Ismail R, Htay MNN, Essar MY, Chauhan S, Patalinghug ME, Kucuk Bicer B, Respati T, Fitriyana S, et al. Digital health literacy for COVID-19 vaccination and intention to be immunized: a cross sectional multi-country study among the general adult population. Front Public Health. 2022;10:998234.CrossRefPubMedPubMedCentral
27.
go back to reference Chirico F, Teixeira da Silva JA, Tsigaris P, Sharun K. Safety & effectiveness of COVID-19 vaccines: a narrative review. Indian J Med Res. 2022;155(1):91–104.CrossRefPubMedPubMedCentral Chirico F, Teixeira da Silva JA, Tsigaris P, Sharun K. Safety & effectiveness of COVID-19 vaccines: a narrative review. Indian J Med Res. 2022;155(1):91–104.CrossRefPubMedPubMedCentral
28.
go back to reference Hause AM, Baggs J, Marquez P, Myers TR, Su JR, Blanc PG, Gwira Baumblatt JA, Woo EJ, Gee J, Shimabukuro TT, et al. Safety Monitoring of COVID-19 vaccine booster doses among adults - United States, September 22, 2021-February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):249–54.CrossRefPubMedPubMedCentral Hause AM, Baggs J, Marquez P, Myers TR, Su JR, Blanc PG, Gwira Baumblatt JA, Woo EJ, Gee J, Shimabukuro TT, et al. Safety Monitoring of COVID-19 vaccine booster doses among adults - United States, September 22, 2021-February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):249–54.CrossRefPubMedPubMedCentral
29.
go back to reference Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021;398(10303):856–69.CrossRefPubMedPubMedCentral Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021;398(10303):856–69.CrossRefPubMedPubMedCentral
30.
go back to reference Normark J, Vikström L, Gwon YD, Persson IL, Edin A, Björsell T, Dernstedt A, Christ W, Tevell S, Evander M, et al. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination. N Engl J Med. 2021;385(11):1049–51.CrossRefPubMed Normark J, Vikström L, Gwon YD, Persson IL, Edin A, Björsell T, Dernstedt A, Christ W, Tevell S, Evander M, et al. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination. N Engl J Med. 2021;385(11):1049–51.CrossRefPubMed
31.
go back to reference Vallée A, Vasse M, Mazaux L, Bonan B, Amiel C, Zia-Chahabi S, Chan-Hew-Wai A, Farfour E, Camps E, Touche P et al. An Immunogenicity Report for the comparison between Heterologous and homologous prime-boost schedules with ChAdOx1-S and BNT162b2 vaccines. J Clin Med 2021, 10(17). Vallée A, Vasse M, Mazaux L, Bonan B, Amiel C, Zia-Chahabi S, Chan-Hew-Wai A, Farfour E, Camps E, Touche P et al. An Immunogenicity Report for the comparison between Heterologous and homologous prime-boost schedules with ChAdOx1-S and BNT162b2 vaccines. J Clin Med 2021, 10(17).
32.
go back to reference Sakr S, Al Khatib A, BouRaad R, Karaki N, El Said H, Sheet I, Hamam BJTOPHJ. Socio-demographic Association with Knowledge, Attitude, and Practice (KAP) towards COVID-19 Vaccines: A Young Population Cross-sectional Study in Lebanon. 2023, 16(1). Sakr S, Al Khatib A, BouRaad R, Karaki N, El Said H, Sheet I, Hamam BJTOPHJ. Socio-demographic Association with Knowledge, Attitude, and Practice (KAP) towards COVID-19 Vaccines: A Young Population Cross-sectional Study in Lebanon. 2023, 16(1).
33.
go back to reference Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, Al-Khalili S, Al-Maani A, Al-Farsi N, Al-Jahwari A, Al-Habsi Z, Al-Shaibi M, Al-Msharfi M et al. Knowledge, attitudes, and practices (KAP) toward the COVID-19 vaccine in Oman: a pre-campaign cross-sectional study. Vaccines (Basel) 2021, 9(6). Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, Al-Khalili S, Al-Maani A, Al-Farsi N, Al-Jahwari A, Al-Habsi Z, Al-Shaibi M, Al-Msharfi M et al. Knowledge, attitudes, and practices (KAP) toward the COVID-19 vaccine in Oman: a pre-campaign cross-sectional study. Vaccines (Basel) 2021, 9(6).
34.
go back to reference Šljivo A, Ćetković A, Abdulkhaliq A, Kiseljaković M, Selimović A, Kulo AJAI. Medicina Preventiva E Di Comunita: COVID-19 vaccination knowledge, attitudes and practices among residents of Bosnia and Herzegovina during the third wave of COVID-19 outbreak. 2022, 34(5). Šljivo A, Ćetković A, Abdulkhaliq A, Kiseljaković M, Selimović A, Kulo AJAI. Medicina Preventiva E Di Comunita: COVID-19 vaccination knowledge, attitudes and practices among residents of Bosnia and Herzegovina during the third wave of COVID-19 outbreak. 2022, 34(5).
35.
go back to reference Hammer CC, Cristea V, Dub T, Sivelä J. High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020. Epidemiol Infect. 2021;149:e123.CrossRefPubMed Hammer CC, Cristea V, Dub T, Sivelä J. High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020. Epidemiol Infect. 2021;149:e123.CrossRefPubMed
36.
go back to reference Brown P, Waite F, Larkin M, Lambe S, McShane H, Pollard AJ, Freeman D. It seems impossible that it’s been made so quickly: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome. Hum Vaccines Immunotherapeutics. 2022;18(1):2004808.CrossRef Brown P, Waite F, Larkin M, Lambe S, McShane H, Pollard AJ, Freeman D. It seems impossible that it’s been made so quickly: a qualitative investigation of concerns about the speed of COVID-19 vaccine development and how these may be overcome. Hum Vaccines Immunotherapeutics. 2022;18(1):2004808.CrossRef
38.
go back to reference Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94.CrossRefPubMedPubMedCentral Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94.CrossRefPubMedPubMedCentral
39.
go back to reference Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366–75.CrossRefPubMed Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366–75.CrossRefPubMed
40.
go back to reference Marzo RR, Sami W, Alam MZ, Acharya S, Jermsittiparsert K, Songwathana K, Pham NT, Respati T, Faller EM, Baldonado AM, et al. Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six southeast Asian countries. Trop Med Health. 2022;50(1):4.CrossRefPubMedPubMedCentral Marzo RR, Sami W, Alam MZ, Acharya S, Jermsittiparsert K, Songwathana K, Pham NT, Respati T, Faller EM, Baldonado AM, et al. Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six southeast Asian countries. Trop Med Health. 2022;50(1):4.CrossRefPubMedPubMedCentral
41.
go back to reference Akter S, Bajinka O, Ashrafuzzaman M, Liu A. The level of Knowledge, Attitudes, and Practices concerning Covid-19 Vaccination and their Determinants in Chittagong District (Bangladesh). 2022. Akter S, Bajinka O, Ashrafuzzaman M, Liu A. The level of Knowledge, Attitudes, and Practices concerning Covid-19 Vaccination and their Determinants in Chittagong District (Bangladesh). 2022.
42.
go back to reference LAS VACUNAS RC: CONOCIMIENTOS. ACTITUDES Y PRÁCTICAS DEL PERSONAL DE SALUD. LAS VACUNAS RC: CONOCIMIENTOS. ACTITUDES Y PRÁCTICAS DEL PERSONAL DE SALUD.
43.
go back to reference Mangla S, Zohra Makkia FT, Pathak AK, Robinson R, Sultana N, Koonisetty KS, Karamehic-Muratovic A, Nguyen UDT, Rodriguez-Morales AJ, Sanchez-Duque JA et al. COVID-19 vaccine hesitancy and emerging variants: evidence from six countries. Behav Sci (Basel) 2021, 11(11). Mangla S, Zohra Makkia FT, Pathak AK, Robinson R, Sultana N, Koonisetty KS, Karamehic-Muratovic A, Nguyen UDT, Rodriguez-Morales AJ, Sanchez-Duque JA et al. COVID-19 vaccine hesitancy and emerging variants: evidence from six countries. Behav Sci (Basel) 2021, 11(11).
44.
go back to reference Nafilyan V, Dolby T, Finning K, Pawelek P, Edge R, Morgan J, Glickman M, Pearce N, van Tongeren MJO, Medicine E. Differences in COVID-19 vaccination coverage by occupation in England: a national linked data study. 2022, 79(11):758–66. Nafilyan V, Dolby T, Finning K, Pawelek P, Edge R, Morgan J, Glickman M, Pearce N, van Tongeren MJO, Medicine E. Differences in COVID-19 vaccination coverage by occupation in England: a national linked data study. 2022, 79(11):758–66.
45.
go back to reference Nafilyan V, Dolby T, Finning K, Pawelek P, Edge R, Morgan J, Glickman M, Pearce N. Tongeren Mv: differences in COVID-19 vaccination coverage by occupation in England: a national linked data study. 2022, 79(11):758–66. Nafilyan V, Dolby T, Finning K, Pawelek P, Edge R, Morgan J, Glickman M, Pearce N. Tongeren Mv: differences in COVID-19 vaccination coverage by occupation in England: a national linked data study. 2022, 79(11):758–66.
46.
go back to reference Reichmuth ML, Heron L, Riou J, Moser A, Hauser A, Low N, Althaus CL. Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study. 2023:2023.2003.2013.23287183. Reichmuth ML, Heron L, Riou J, Moser A, Hauser A, Low N, Althaus CL. Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study. 2023:2023.2003.2013.23287183.
47.
go back to reference Reichmuth ML, Heron L, Riou J, Moser A, Hauser A, Low N, Althaus CL. Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study. BMC Public Health. 2023;23(1):1523.CrossRefPubMedPubMedCentral Reichmuth ML, Heron L, Riou J, Moser A, Hauser A, Low N, Althaus CL. Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study. BMC Public Health. 2023;23(1):1523.CrossRefPubMedPubMedCentral
48.
go back to reference García-Pachón E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martínez C, Grau-Delgado J, Padilla-Navas I, Gutiérrez F. Asthma and COPD in hospitalized COVID-19 patients. Arch Bronconeumol. 2020;56(9):604–6.CrossRefPubMedPubMedCentral García-Pachón E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martínez C, Grau-Delgado J, Padilla-Navas I, Gutiérrez F. Asthma and COPD in hospitalized COVID-19 patients. Arch Bronconeumol. 2020;56(9):604–6.CrossRefPubMedPubMedCentral
49.
go back to reference Broadhurst R, Peterson R, Wisnivesky JP, Federman A, Zimmer SM, Sharma S, Wechsler M, Holguin F. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc. 2020;17(12):1645–8.CrossRefPubMedPubMedCentral Broadhurst R, Peterson R, Wisnivesky JP, Federman A, Zimmer SM, Sharma S, Wechsler M, Holguin F. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc. 2020;17(12):1645–8.CrossRefPubMedPubMedCentral
50.
go back to reference Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma protective against COVID-19? Allergy. 2021;76(3):866–8.CrossRefPubMed Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Is asthma protective against COVID-19? Allergy. 2021;76(3):866–8.CrossRefPubMed
52.
go back to reference Parker EPK, Horne EMF, Hulme WJ, Tazare J, Zheng B, Carr EJ, Loud F, Lyon S, Mahalingasivam V, MacKenna B, et al. Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. Lancet Reg Health Eur. 2023;30:100636.CrossRefPubMedPubMedCentral Parker EPK, Horne EMF, Hulme WJ, Tazare J, Zheng B, Carr EJ, Loud F, Lyon S, Mahalingasivam V, MacKenna B, et al. Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. Lancet Reg Health Eur. 2023;30:100636.CrossRefPubMedPubMedCentral
53.
go back to reference Elsayed M, El-Abasiri RA, Dardeer KT, Kamal MA, Htay MNN, Abler B, Marzo RR. Factors influencing decision making regarding the Acceptance of the COVID-19 vaccination in Egypt: a cross-sectional study in an Urban, Well-Educated Sample. Vaccines (Basel) 2021, 10(1). Elsayed M, El-Abasiri RA, Dardeer KT, Kamal MA, Htay MNN, Abler B, Marzo RR. Factors influencing decision making regarding the Acceptance of the COVID-19 vaccination in Egypt: a cross-sectional study in an Urban, Well-Educated Sample. Vaccines (Basel) 2021, 10(1).
54.
go back to reference Marzo RR, Ahmad A, Abid K, Khatiwada AP, Ahmed A, Kyaw TM, Abidin IBZ, Srithar M, Sinnathamby S, Sarvasundram AP, et al. Factors influencing the acceptability of COVID-19 vaccination: a cross-sectional study from Malaysia. Vacunas. 2022;23:S33–40.CrossRefPubMed Marzo RR, Ahmad A, Abid K, Khatiwada AP, Ahmed A, Kyaw TM, Abidin IBZ, Srithar M, Sinnathamby S, Sarvasundram AP, et al. Factors influencing the acceptability of COVID-19 vaccination: a cross-sectional study from Malaysia. Vacunas. 2022;23:S33–40.CrossRefPubMed
55.
go back to reference Šljivo A, Kačamaković M, Siručić I, Mujičić E, Džubur Kulenović A. Knowledge, attitudes, and practices towards COVID-19 among residents of Bosnia and Herzegovina during the first stage of COVID-19 outbreak. Annali Di Igiene: Med Preventiva e di Comunita. 2021;33(4):371–80. Šljivo A, Kačamaković M, Siručić I, Mujičić E, Džubur Kulenović A. Knowledge, attitudes, and practices towards COVID-19 among residents of Bosnia and Herzegovina during the first stage of COVID-19 outbreak. Annali Di Igiene: Med Preventiva e di Comunita. 2021;33(4):371–80.
56.
go back to reference Ashour HA, Alhinti SF, Hawsaoi SA, Alsuwailem AA, AlFarhan A, Abdulmajeed I. Knowledge, attitude, and practice (KAP) of COVID-19 vaccine among Saudi mothers. Cureus. 2023;15(3):e36826.PubMedPubMedCentral Ashour HA, Alhinti SF, Hawsaoi SA, Alsuwailem AA, AlFarhan A, Abdulmajeed I. Knowledge, attitude, and practice (KAP) of COVID-19 vaccine among Saudi mothers. Cureus. 2023;15(3):e36826.PubMedPubMedCentral
Metadata
Title
Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
Authors
Fabián R. Chacón-Labrador
María G. Passantino
Augusto Moncada-Ortega
Atahualpa A. Ávila
Andrea A. Moreno
Nicolle A. Kuffaty-Akkou
Luisana M. Pedroza
Natasha A. Camejo-Ávila
Daniela L. Mendoza-Millán
Carlis M. Rodriguez-Saavedra
María V. Marcano-Rojas
Fernando Hernández-Medina
María E. Grillet
Fhabián S. Carrión-Nessi
David A. Forero-Peña
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18598-4

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue